Search Results
426 results found with an empty search
- Smither's Hemp & CBD Workshop | Asa Waldstein
< Back Panel Discussion Thursday Oct 7, 2021 Smither's Hemp & CBD Workshop Online Event Moderator: Asa Waldstein Expert panelists: Vanessa Snyder from Eurofins David Dawson, Ph.D. from Via Innovations Alex Capano, from Ecofibre Limited Dr Parveen Bhatarah from Association for the Cannabinoid Industry Alex: What textile and food innovations that you are excited about? Please talk about what market segments you are interested in (Scientific & Category Perspective) (Alex feel free to reframe this question) Please share some of the eco-benefits of the wonderful hemp plant. David: What do you look for in a cannabis or hemp testing lab? What cannabis and nutraceutical delivery forms are you excited about and what are some of the hindrances in bringing them to commercialization? Vanessa: With so many labs in the space, how do you explain to customers what to look for in a reputable lab? Are there certain form factors that are difficult to test (gummies or liposomes) and how do Eurofins handle this? How do you see the future of hemp looking as an ingredient in animal feed? Parveen: What considerations should US supplement companies that are looking to expand into the UK be aware of? What are some of the key drivers for the hemp sector investment, and what can companies be working on to attract funding? Watch the panel recording Previous Next
- Privacy Policy | Asa Waldstein
AsaWaldstein.com Online Privacy Policy Agreement November 24, 2020 Regulatory Education Events LLC dba Supplement Advisory Group LLC (AsaWaldstein.com) values its users' privacy. This Privacy Policy ("Policy") will help you understand how we collect and use personal information from those who visit our website or make use of our online facilities and services, and what we will and will not do with the information we collect. Our Policy has been designed and created to ensure those affiliated with Regulatory Education Events LLC of our commitment and realization of our obligation not only to meet, but to exceed, most existing privacy standards. We reserve the right to make changes to this Policy at any given time. If you want to make sure that you are up to date with the latest changes, we advise you to frequently visit this page. If at any point in time Regulatory Education Events LLC decides to make use of any personally identifiable information on file, in a manner vastly different from that which was stated when this information was initially collected, the user or users shall be promptly notified by email. Users at that time shall have the option as to whether to permit the use of their information in this separate manner. This Policy applies to Regulatory Education Events LLC and any subsidiary company listed below, and it governs any and all data collection and usage by us. Through the use of www.AsaWaldstein.com and any subsidiary website listed below, you are therefore consenting to the data collection procedures expressed in this Policy. Subsidiary Company: Supplement Advisory Group Subsidiary Website: AsaWaldstein.com Please note that this Policy does not govern the collection and use of information by companies that Regulatory Education Events LLC does not control, nor by individuals not employed or managed by us. If you visit a website that we mention or link to, be sure to review its privacy policy before providing the site with information. It is highly recommended and suggested that you review the privacy policies and statements of any website you choose to use or frequent to better understand the way in which websites garner, make use of and share the information collected. Specifically, this Policy will inform you of the following What personally identifiable information is collected from you through our website; Why we collect personally identifiable information and the legal basis for such collection; How we use the collected information and with whom it may be shared; What choices are available to you regarding the use of your data; and The security procedures in place to protect the misuse of your information. Information We Collect It is always up to you whether to disclose personally identifiable information to us, although if you elect not to do so, we reserve the right not to register you as a user or provide you with any products or services. This website collects various types of information, such as: Voluntarily provided information which may include your name, address, email address, billing and/or credit card information etc. which may be used when you purchase products and/or services and to deliver the services you have requested. Information automatically collected when visiting our website, which may include cookies, third party tracking technologies and server logs. In addition, Regulatory Education Events LLC may have the occasion to collect non-personal anonymous demographic information, such as age, gender, household income, political affiliation, race and religion, as well as the type of browser you are using, IP address, or type of operating system, which will assist us in providing and maintaining superior quality service. Regulatory Education Events LLC may also deem it necessary, from time to time, to follow websites that our users may frequent to gleam what types of services and products may be the most popular to customers or the general public. Please rest assured that this site will only collect personal information that you knowingly and willingly provide to us by way of surveys, completed membership forms, and emails. It is the intent of this site to use personal information only for the purpose for which it was requested, and any additional uses specifically provided for on this Policy. Why We Collect Information and For How Long We are collecting your data for several reasons: To better understand your needs and provide you with the services you have requested; To fulfill our legitimate interest in improving our services and products; To send you promotional emails containing information we think you may like when we have your consent to do so; To contact you to fill out surveys or participate in other types of market research, when we have your consent to do so; To customize our website according to your online behavior and personal preferences. The data we collect from you will be stored for no longer than necessary. The length of time we retain said information will be determined based upon the following criteria: the length of time your personal information remains relevant; the length of time it is reasonable to keep records to demonstrate that we have fulfilled our duties and obligations; any limitation periods within which claims might be made; any retention periods prescribed by law or recommended by regulators, professional bodies or associations; the type of contract we have with you, the existence of your consent, and our legitimate interest in keeping such information as stated in this Policy. Use of Information Collected Regulatory Education Events LLC does not now, nor will it in the future, sell, rent or lease any of its customer lists and/or names to any third parties. Regulatory Education Events LLC may collect and may make use of personal information to assist in the operation of our website and to ensure delivery of the services you need and request. At times, we may find it necessary to use personally identifiable information as a means to keep you informed of other possible products and/or services that may be available to you from www.AsaWaldstein.com and its subsidiaries. Regulatory Education Events LLC and its subsidiaries may also be in contact with you with regards to completing surveys and/or research questionnaires related to your opinion of current or potential future services that may be offered. Regulatory Education Events LLC uses various third-party social media features including but not limited to Facebook, Twitter, YouTube, LinkedIn and other interactive programs. These may collect your IP address and require cookies to work properly. These services are governed by the privacy policies of the providers and are not within Regulatory Education Events LLC's control. Disclosure of Information Regulatory Education Events LLC may not use or disclose the information provided by you except under the following circumstances: as necessary to provide services or products you have ordered; in other ways described in this Policy or to which you have otherwise consented; in the aggregate with other information in such a way so that your identity cannot reasonably be determined; as required by law, or in response to a subpoena or search warrant; to outside auditors who have agreed to keep the information confidential; as necessary to enforce the Terms of Service; as necessary to maintain, safeguard and preserve all the rights and property of Regulatory Education Events LLC. Non-Marketing Purposes Regulatory Education Events LLC greatly respects your privacy. We do maintain and reserve the right to contact you if needed for non-marketing purposes (such as bug alerts, security breaches, account issues, and/or changes in Regulatory Education Events LLC products and services). In certain circumstances, we may use our website, newspapers, or other public means to post a notice. Children under the age of 13 Regulatory Education Events LLC's website is not directed to, and does not knowingly collect personal identifiable information from, children under the age of thirteen (13). If it is determined that such information has been inadvertently collected on anyone under the age of thirteen (13), we shall immediately take the necessary steps to ensure that such information is deleted from our system's database, or in the alternative, that verifiable parental consent is obtained for the use and storage of such information. Anyone under the age of thirteen (13) must seek and obtain parent or guardian permission to use this website. Unsubscribe or Opt-Out All users and visitors to our website have the option to discontinue receiving communications from us by way of email or newsletters. To discontinue or unsubscribe from our website please send an email that you wish to unsubscribe to Asa@AsaWaldstein.com . If you wish to unsubscribe or opt-out from any third-party websites, you must go to that specific website to unsubscribe or opt-out. Regulatory Education Events LLC will continue to adhere to this Policy with respect to any personal information previously collected. Links to Other Websites Our website does contain links to affiliate and other websites. Regulatory Education Events LLC does not claim nor accept responsibility for any privacy policies, practices and/or procedures of other such websites. Therefore, we encourage all users and visitors to be aware when they leave our website and to read the privacy statements of every website that collects personally identifiable information. This Privacy Policy Agreement applies only and solely to the information collected by our website. Notice to European Union Users Regulatory Education Events LLC's operations are located primarily in the United States. If you provide information to us, the information will be transferred out of the European Union (EU) and sent to the United States. (The adequacy decision on the EU-US Privacy became operational on August 1, 2016. This framework protects the fundamental rights of anyone in the EU whose personal data is transferred to the United States for commercial purposes. It allows the free transfer of data to companies that are certified in the US under the Privacy Shield.) By providing personal information to us, you are consenting to its storage and use as described in this Policy. Security Regulatory Education Events LLC takes precautions to protect your information. When you submit sensitive information via the website, your information is protected both online and offline. Wherever we collect sensitive information (e.g. credit card information), that information is encrypted and transmitted to us in a secure way. You can verify this by looking for a lock icon in the address bar and looking for "https" at the beginning of the address of the webpage. While we use encryption to protect sensitive information transmitted online, we also protect your information offline. Only employees who need the information to perform a specific job (for example, billing or customer service) are granted access to personally identifiable information. The computers and servers in which we store personally identifiable information are kept in a secure environment. This is all done to prevent any loss, misuse, unauthorized access, disclosure or modification of the user's personal information under our control. The company also uses Secure Socket Layer (SSL) for authentication and private communications to build users' trust and confidence in the internet and website use by providing simple and secure access and communication of credit card and personal information. Acceptance of Terms By using this website, you are hereby accepting the terms and conditions stipulated within the Privacy Policy Agreement. If you are not in agreement with our terms and conditions, then you should refrain from further use of our sites. In addition, your continued use of our website. following the posting of any updates or changes to our terms and conditions shall mean that you agree and acceptance of such changes. How to Contact Us If you have any questions or concerns regarding the Privacy Policy Agreement related to our website, please feel free to contact us at the following email, telephone number or mailing address. Email: Asa@AsaWaldstein.com Mailing Address: Regulatory Education Events LLC, GDPR Disclosure: If you answered "yes" to the question Does your website comply with the General Data Protection Regulation ("GDPR")? then the Privacy Policy above includes language that is meant to account for such compliance. Nevertheless, in order to be fully compliant with GDPR regulations your company must fulfill other requirements such as: (i) doing an assessment of data processing activities to improve security; (ii) have a data processing agreement with any third party vendors; (iii) appoint a data protection officer for the company to monitor GDPR compliance; (iv) designate a representative based in the EU under certain circumstances; and (v) have a protocol in place to handle a potential data breach. For more details on how to make sure your company is fully compliant with GDPR, please visit the official website at https://gdpr.eu. FormSwift and its subsidiaries are in no way responsible for determining whether or not your company is in fact compliant with GDPR and takes no responsibility for the use you make of this Privacy Policy or for any potential liability your company may face in relation to any GDPR compliance issues. COPPA Compliance Disclosure: This Privacy Policy presumes that your website is not directed at children under the age of 13 and does not knowingly collect personal identifiable information from them or allow others to do the same through your site. If this is not true for your website or online service and you do collect such information (or allow others to do so), please be aware that you must be compliant with all COPPA regulations and guidelines in order to avoid violations which could lead to law enforcement actions, including civil penalties. In order to be fully compliant with COPPA your website or online service must fulfill other requirements such as: (i) posting a privacy policy which describes not only your practices, but also the practices of any others collecting personal information on your site or service — for example, plug-ins or ad networks; (ii) include a prominent link to your privacy policy anywhere you collect personal information from children; (iii) include a description of parental rights (e.g. that you won't require a child to disclose more information than is reasonably necessary, that they can review their child's personal information, direct you to delete it, and refuse to allow any further collection or use of the child's information, and the procedures to exercise their rights); (iv) give parents "direct notice" of your information practices before collecting information from their children; and (v) obtain the parents' "verifiable consent" before collecting, using or disclosing personal information from a child. For more information on the definition of these terms and how to make sure your website or online service is fully compliant with COPPA please visit https://www.ftc.gov/tips-advice/business-center/guidance/childrens-online- privacy-protection-rule-six-step-compliance. FormSwift and its subsidiaries are in no way responsible for determining whether or not your company is in fact compliant with COPPA and takes no responsibility for the use you make of this Privacy Policy or for any potential liability your company may face in relation to any COPPA compliance issues.
- Why Hemp-CBD Companies Need a Supplement Executive | Asa Waldstein
< Back Interview Saturday Jun 20, 2020 Why Hemp-CBD Companies Need a Supplement Executive NutraCast Maximizing sales by decreasing the time to get to operational efficiency is important. Learning on the job when it comes to best interpreting GMP's, knowing what machinery companies to purchase from, how to market products effectively and compliantly can slow the time to get to maximum peak performance. Focus on sales rather than being bogged down in the "learning curve"stages of growth by hiring an industry expert. We discuss this and more during our fun discussion. Listen Previous Next
- Warning Letter Wednesday Signup | Asa Waldstein
Warning Letter Wednesday Sign-up Don't miss an issue sign-up today A weekly exploration of FDA warning letters and enforcement trends
- Labeling Compliance Resources
Some of our favorite resources to help educate about labeling compliance. Labeling Compliance / Labeling Compliance These are common areas of enforcement and lawsuits.Here are some resources to help understand these regulations. FDA label claim guidance Compliance essentials for CBD companies: Labeling Back
- Leveraging AI in Dietary Supplement R&D: Harnessing Innovation While Navigating Key Regulatory and IP Risks | Asa Waldstein
< Back In-Person, Panel Discussion Wednesday Jun 25, 2025 Leveraging AI in Dietary Supplement R&D: Harnessing Innovation While Navigating Key Regulatory and IP Risks American Conference Institute New York, NY As the dietary supplements industry continues to evolve, innovation is driving new product development and improved efficiencies. From AI-powered R&D to advancements in manufacturing and supply chain optimization, companies are embracing cutting-edge technologies to stay competitive. However, these innovations also introduce complex regulatory, intellectual property, and compliance risks that must be carefully navigated. Join industry leaders and experts as they explore: AI’s role in dietary supplement R&D and product development: how artificial intelligence is transforming ingredient discovery, formulation, and clinical research Understanding the applicable guidelines for using AI to support regulatory submissions/documents (GRAS, NDI, claims registrations, etc.) focused on safety, quality and efficacy of ingredients Navigating evolving FDA oversight and safety considerations when utilizing AI in product development Understanding the IP and competitive risks: navigating issues that can arise regarding the patentability of AI-discovered ingredients and formulations Learn More and Register Previous Next
- AHPA leans on past to embrace high-tech future at botanical congress
The American Herbal Products Association hosted its first botanical congress outside the confines of the SupplySide Global trade show. < Back AHPA leans on past to embrace high-tech future at botanical congress Claudia Adrien Press Mention The American Herbal Products Association hosted its first botanical congress outside the confines of the SupplySide Global trade show. Read More Previous Next
- Marketing Compliance Resources
Some of our favorite resources to help educate about marketing compliance. Marketing Compliance / Marketing Compliance These are common areas of enforcement and lawsuits.Here are some resources to help understand these regulations. Substantiation Tips and CARSE Health Products Compliance Guidance TikTok Music Copyright Litigation & Best Practices Common Plaintiff Lawsuits: Best Practices Asa's weekly Warning Letter Wednesday post FTC Document: How to Make Effective Disclosures in Digital Advertising FTC Document: Social Media Disclosures FTC's Dietary Supplement Advertising Guide For Industry Made in the USA lawsuit reference (TINA) Natural Claims article Made in the USA (Great Podcast!) Made in the USA FTC Guidance AHPA Hemp CBD Supplement Congress videos! FDA Label Claim Guidance FTC Guidance: Claim Substantiation FTC Guides Concerning the Use of Endorsements and Testimonials in Advertising AHPA Alerts: Stay up to date (AHPA members only) Other AHPA Guidance Documents Compliance essential for hemp CBD companies: Marketing FDA alerts (allergens, recalls, warning letters) Back
- KISC My Health Radio Show with Captain Cran Man Stephen Lukawski with Asa Waldstein and cohost Peter Mingils
Asa Waldstein is our guest on KISC My Health Radio show with Peter Mingils and the King of Cranberries Stephen Lukawski. < Back KISC My Health Radio Show with Captain Cran Man Stephen Lukawski with Asa Waldstein and cohost Peter Mingils Stephen Lukawski Podcast Interview Asa Waldstein is our guest on KISC My Health Radio show with Peter Mingils and the King of Cranberries Stephen Lukawski. This week on KISC My Health Radio, Captain Cran Man Stephen Lukawski and Peter Mingils have the privilege of interviewing Asa Waldstein. Click "read more" below to learn more and listen to the interview. Read More Previous Next
- Influencers and CBD: Be Careful What You Say
Asa is interviewed by a well-known influencer on the topic. This is applicable to the dietary supplement industry as well. Read here: https://www.letstalkhemp.com/hemp-influencers/ < Back Influencers and CBD: Be Careful What You Say Cait Curley and Asa Waldstein Interview Asa is interviewed by a well-known influencer on the topic. This is applicable to the dietary supplement industry as well. Read here: https://www.letstalkhemp.com/hemp-influencers/ Read More Previous Next
- Improper Written Specifications Lead To Warning Letter
Batch records should be complete < Back Improper Written Specifications Lead To Warning Letter Batch records should be complete This warning letter is interesting as it details some of FDA's thinking on test methods. Upon my initial reading of this letter, it seemed like FDA had an issue with HPTLC, but the problem was actually how the specification was written. HPTLC is mentioned in this letter. Here FDA states that HPTLC is not a parameter that can be tested to. More information is needed, such as the plant’s genus, species, and the plant part. From warning letter. “HPTLC” is not a qualitative or quantitative parameter to which a test result can be compared to verify the identity of the component.” Thanks to my friends at Alkemist Labs for talking this through with me. Your expertise is very appreciated! This is a shortened version of Warning Letter Wednesday as I’m currently attending Supplyside West. If you are here and want to discuss consulting or Apex Compliance™ Compliance, let me know. There are also other GMP violations in the letter, such as incomplete batch records. This example FDA cites the company for not having cleaning records. When I was a manufacturer, we would attach cleaning records to each batch record. As FDA notes below, this is not needed, but cross-referencing this information is required. 👉 From warning letter. “Your batch production record fails to include the date and time of the maintenance, cleaning, and sanitizing of the equipment and processing lines used in producing the batch or a cross-reference to records, such as individual equipment logs, where this information is retained.” I recommend reading the full warning letter , as there are other labeling and testing citations that provide good learning opportunities. Disclaimer: The educational information provided here is for informational purposes only. Contact an attorney for specific legal advice. Rule #1 in compliance is to ensure marketing is truthful and not misleading. Previous Next Get Warning Letter Wednesday in your Inbox Sign-Up Now!
- “Blood sugar” enforcement risks and review
Use caution when promoting blood sugar products. Remove claims on social media. < Back “Blood sugar” enforcement risks and review Use caution when promoting blood sugar products. Remove claims on social media. #WarningLetterWednesday; Blood sugar claims enforcement remains top of mind for the FDA. Since January 2021, there have been 36 blood sugar related warning letters. 🔷Blood sugar support is not a high-risk claim, but it becomes very high-risk when correlated with a disease such as diabetes. Not surprisingly, nearly 78% of the warning letters include the words diabetes or diabetic. The remaining eight that only mentioned "blood sugar" also contain high-risk words such as cancer and depression. These claims were made on Amazon, social media, testimonials, videos, and product tags. I expect to see more warning letters calling out claims on these platforms, especially with claims made in videos and testimonials. 🔷Testimonials: Claims made in testimonials were cited nearly 30% of the time, which is a strong enforcement trend to be aware of. Here is a video about why product reviews and testimonials can be considered marketing claims. 🔷Blogs: 22% of the warning letters include claims made in blogs. The line between "educational" and "product blogs" is thin. I talk about this here . 👉Here is a learning tool titled "Protect Your Company: Learn to read warning letters ." 🔷Social Media: Claims made on social media represent nearly 64% of these letters. The FDA is paying close attention to social media posts. I expect the number of social media related warning letters to increase, especially since the FDA is going back several years on company social media posts. They look at several year old posts in the same manner as current ones. Here is a video about reasons to clean up old social media posts. 🔷Hashtags: 25% of these letters include claims made in hashtags. This is a strong enforcement trend to watch. Here is a video about this. 🔷🔷Key Takeaways🔷🔷 👉Blood sugar marketing statements should be used with caution. 👉The word diabetes should be avoided. 👉Remove claims and high-risk words on all marketing platforms . 👉Blogs, hashtags, and social media are under increased scrutiny. What enforcement trends are interesting to you? Disclaimer: The educational information provided here is for informational purposes only. Contact an attorney for specific legal advice. Rule #1 in compliance is to ensure marketing is truthful and not misleading. Previous Next Get Warning Letter Wednesday in your Inbox Sign-Up Now!





